9/21/2011 10:46:35 AM
PRINCETON, N.J.--(BUSINESS WIRE)--Celator Pharmaceuticals today announced that U.S. Patent No. 8,022,279 was issued by the United States Patent and Trademark Office on September 20, 2011 and that two related patents in Japan have been granted as well. These patents add to the intellectual property surrounding Celator’s lead anti-leukemia drug, CPX-351.
comments powered by